https://www.selleckchem.com/pr....oducts/pf-07104091.h
012) was also associated with a temporal increase in the percentage of patients aged ≧75years. Proportion of patients ≧75years of age for de novo CIED implantation gradually increased from 2006 to 2016, presumably because of the growing number of nonischemic cardiomyopathy and heart failure patients requiring primary prevention of sudden cardiac death. Proportion of patients ≧75 years of age for de novo CIED implantation gradually increased from 2006 to 2016, presumably because of the growing number of nonischemic cardiomyopathy and
Aimer
Commentaire
Partagez
